These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4395458)

  • 1. Haemodynamic effects of intravenous oxoprenolol.
    Bensaid J; Scebat L; Lenegre J
    Postgrad Med J; 1970 Nov; ():Suppl:49-56. PubMed ID: 4395458
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodynamic effects of oxprenolol in hypertensive patients.
    Majid PA; Sharma B; Saxton C; Stoker JB; Taylor SH
    Postgrad Med J; 1970 Nov; ():Suppl:67-72. PubMed ID: 4395462
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of a new beta-receptor blockader (LB 46, Visken) on systemic and pulmonary hemodynamics and on coronary blood flow in humans].
    Dolder M; Kaufmann M; Gurtner HP
    Schweiz Med Wochenschr; 1971 Dec; 101(51):1869-76. PubMed ID: 4400986
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the effects of an beta-adrenolytic substance on the functional parameters of blood circulation].
    Noder W
    Z Kreislaufforsch; 1969 Apr; 58(4):440-7. PubMed ID: 5799929
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic effects of a new inhibitor of adrenergic beta receptors (LB 46)].
    Lejwi G; Fabiato A; Gut JP; Gourgon R
    Arch Mal Coeur Vaiss; 1971 Nov; 64(11):1654-68. PubMed ID: 4402388
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of ICI 50,172 on cardio-respiratory parameters in dogs].
    Tavares P; Viana AR; Ximenes-Neto M; Martinelli JG
    Rev Bras Anestesiol; 1971; 21(4):596-601. PubMed ID: 4401689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of a new beta receptor blockader on hemodynamics].
    Bross W; Kustrzycki A; Olejak B; Bross T; Koltowski R; Masiak M
    Med Klin; 1972 Mar; 67(11):373-81. PubMed ID: 4401684
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
    [No Abstract]   [Full Text] [Related]  

  • 11. [Selective beta-blocking action of practolol (ICI 50.172)].
    Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
    Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
    [No Abstract]   [Full Text] [Related]  

  • 12. Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.
    Ekelund LG; Melcher A; Orö L
    Eur J Clin Pharmacol; 1971 Sep; 3(4):198-203. PubMed ID: 5151303
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of haemodynamic effects of oxprenolol (trasicor), alprenolol (aptin), and sotalol (MJ 1999) in man.
    Gibson DG; Hoy J; Sowton E
    Br Heart J; 1970 Jul; 32(4):553. PubMed ID: 4393535
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemodynamic effects of practolol.
    Gibson DG; Coltart DJ
    Br Heart J; 1972 Jan; 34(1):95-9. PubMed ID: 4400624
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions].
    Starcich R; Barbaresi F; Bacuzzi E; Valentino RV
    Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects on the hemodynamics and myocardial contractility of 2 beta blockader agents: propranolol and proctolol].
    Sanguinetti M; Picchio FM; Maresta A; Branzi A; Baccarani G; Binetti G
    G Ital Cardiol; 1972; 2(5):710-9. PubMed ID: 4404053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quantitative comparison of the effects of various beta-adrenergic receptor antagonists in healthy subjects at rest and during infusions of isoproterenol].
    Bender F; Sieger W; Dotterweich K
    Arztl Forsch; 1969 Nov; 23(11):359-65. PubMed ID: 4391417
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical pharmacology of beta-sympathicolysis. Comparative trial of LB 46 and propranolol].
    Lang E; Haas W; Heck J
    Med Klin; 1970 Dec; 65(50):2206-11. PubMed ID: 4399179
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.